Chronic treatment with probucol effectively inhibits progression of pulmonary hypertension in rats.
It has been reported that probucol is a lipid-lowering agent having a strong antioxidative effect and inhibitory action on vascular smooth muscle cell proliferation. In this work, we studied the effect of treatment with a 1% probucol diet on pulmonary hypertension induced by monocrotaline (MCT) in rats. Rats were fed a control or 1% probucol-supplemented diet for 7 days, then given a single subcutaneous injection of 60 mg/kg MCT or saline, and continuously fed the same diet for 20 days, respectively. MCT caused an increase in right ventricular systolic pressure (RVSP), an indicator of pulmonary hypertension, and central venous pressure (CVP) on day 20. In rats receiving a diet containing 1% probucol, RVSP was significantly lower than that in rats treated with control diet, and CVP remained essentially at the basal level. On day 20, MCT also caused an increase in the ratio of right ventricular (RV) to body weight (BW), compared to the control value, indicating the development of RV hypertrophy in MCT rats. RV hypertrophy was significantly inhibited in 1% probucol-treated rats. These findings suggest that chronic treatment with probucol effectively inhibits the progression of pulmonary hypertension in rats.
Irukayama-Tomobe
Y
Y
Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Ibaraki, Japan.
Sakai
S
S
Miyauchi
T
T
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001794:Blood Pressure / Q000187:drug effects; D004032:Diet; D018450:Disease Progression; D006976:Hypertension, Pulmonary / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D017380:Hypertrophy, Right Ventricular / Q000139:chemically induced / Q000517:prevention & control; D008297:Male; D016686:Monocrotaline; D011341:Probucol / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D018497:Ventricular Dysfunction, Right / Q000139:chemically induced / Q000188:drug therapy; D016278:Ventricular Function, Right / Q000187:drug effects; D017725:Ventricular Pressure
D000924:Anticholesteremic Agents; D016686:Monocrotaline; D011341:Probucol